SWOG clinical trial number
SWOG-9015

A Randomized Trial of Pre- and Post-Operative Chemotherapy Compared to Surgery Alone for Patients with Operable Non Small Cell Carcinoma of the Lung, Phase III

Closed
Phase
Accrual
5%
Abbreviated Title
A Randomized Trial of Pre- and Post-Operative Chemotherapy Compared to Surgery Alone for Patients with Operable Non Small Cell Carcinoma of the Lung, Phase III
Activated
05/15/1992
Closed
03/15/1994

Research committees

Lung Cancer

Publication Information Expand/Collapse

2014

Pre-operative chemotherapy for non-small cell lung cancer: a systematic review and meta-analysis of individual particpant data. [P. Bunn and K. Pisters collaborators]

S Burdett;NSCLC Meta-analysis Collab Grp Lancet 383(9928):1561-1571;

PMid: PMID24576776 | PMC number: PMC4022989

Other Clinical Trials

SWOG Clinical Trial Number
S2409

PRISM: PRecIsion in SCLC via a Multicohort Study: Randomized Phase II studies evaluating maintenance Durvalumab with or without Biomarker-Directed Therapy for Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Research Committee(s)
Lung Cancer
Activated
09/08/2025
Accrual
0%
Open
Phase
SWOG Clinical Trial Number
CTSU/EA5231

A Randomized Phase III Trial of Checkpoint Blockade in Lung Cance3r Patients in the Adjuvant Setting Based on Pathologic Response Following Neoadjuvant Therapy (CLEAR)
Research Committee(s)
Lung Cancer
Activated
06/13/2025
Open
Phase
SWOG Clinical Trial Number
S2414

INcorporating pathologic reSponse in patIents with early staGe lung cancer to optimize immunotHerapy in the adjuvanT setting (INSIGHT)
Research Committee(s)
Lung Cancer
Symptom Management and Survivorship
Activated
03/14/2025
Accrual
2%
Open
Phase